In a kinome-wide screening of mesenchymal-like transcriptional activation in human glioblastoma-derived endothelial cells, PAK4 was identified as a selective regulator of genetic reprogramming in tumour vasculature, leading to aberrant vascularisation [85]. The gene discussed is PAK4; the disease is neoplasm.